Anti-spike and neutralizing antibodies after two doses of covid-19 sinopharm/bibp vaccine

HIGHLIGHTS

  • who: Eman A. Omran and colleagues from the Department of Microbiology, High Institute of Public Health, University, El-Horreya have published the research: Anti-Spike and Neutralizing Antibodies after Two Doses of COVID-19 Sinopharm/BIBP Vaccine, in the Journal: Vaccines 2022, 10, x FOR PEER REVIEW of 29/05/2022
  • what: The aim of this cross-sectional study was to investigate the antibody response after receiving two Sinopharm vaccine doses.
  • future: In the study the small number of hypertensive participants might have affected the significance of the findings thus more studies with . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?